Modern medicine has changed the world. In 1900, the average life expectancy of a newborn was 32 years. By 2021 this had more than doubled to 71 years.
But globally, we now spend a staggering $10 trillion annually on healthcare, representing about 10% of the world’s GDP. The United States, with just 4% of the global population, accounts for a remarkable 40% of this expenditure, amounting to over 16% of the U.S. GDP.
In the U.S., the predominantly private healthcare system benefits from the financial rewards of healthcare usage and innovation, driving both consumption and progress. This often overpriced and over-consumed system is currently fueling global advancements in medical technology and practices.
The future of healthcare will be different. We foresee a shift towards a more cost-effective and sustainable model of healthcare innovation. At Stamford 40, our mission is to predict, invest, and build the future of medicine.
Join us on this journey.
A clinical-stage biotechnology company developing drugs that address metabolic targets in neurological diseases.
Developing life-changing ketogenic medicines for the treatment of epilepsy and rare orphan diseases.
Send us a message
100 Tras Street, Downtown Core, Singapore 079027
Copyright © 2024 Stamford40 - All Rights Reserved.
Powered by Rupsta Media